Advertisement

Breast Cancer Research and Treatment

, Volume 111, Issue 2, pp 355–364 | Cite as

The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method

  • Katherine H. Rak TkaczukEmail author
  • Olga Goloubeva
  • Nancy S. Tait
  • Faye Feldman
  • Ming Tan
  • Zhao-Ping Lum
  • Stephen A. Lesko
  • David A. Van Echo
  • Paul O. P. Ts’o
Clinical Trial

Abstract

Purpose: A negative selection method for the enumeration and characterization of circulating epithelial/cancer cells (CCC) in Breast Cancer (BC) patients is described. This manual procedure yields reproducible results of high sensitivity and selectivity suitable for research laboratories. Patients and methods: We conducted a prospective blood sampling study in 105 women with stage 1–4 BC attending clinics at the University of Maryland Greenebaum Cancer Center to define the prevalence of CCC utilizing our sensitive double gradient centrifugation and magnetic cell sorting CCC detection and enumeration method. CCC were isolated and enumerated from 15 to 20 ml of venous blood drawn before the start of systemic therapy and periodically thereafter for up to 24 months. One or more CCC/sample was considered a positive result. Results: We analyzed 487samples for the presence of CCC; the median number of samples/patient was 4 (range 1–8). CCC were detected in 56% of patients, 19%—stage 1; 43%—stage 2; 46%—stage 3; 83%—stage 4. The probability of being positive for the presence of CCC is significantly associated with the stage of cancer (P < 0.0001). The frequency of CCC positive patients and samples increased with the advancing stage of disease. Presence of more than 10 CCC/sample was associated with the decreased survival and increased probability of having metastatic disease P = 0.001. Conclusions: Increasing number of CCC/sample correlates with the adverse outcome and poorer survival (P < 0.0001). Our CCC test based on the negative selection procedure may provide valuable prognostic information.

Keywords

Breast Cancer Stage 1-4 Circulating epithelial cells Negative selection method Prospective blood sampling study Association of numbers of epithelial cells with survival 

Notes

Acknowledgement

The work done at CCC Diagnostics LLC is supported by NCI Grant #CA081903.

References

  1. 1.
    Cristofanilli M et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8):781–791PubMedCrossRefGoogle Scholar
  2. 2.
    Cristofanilli M et al (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23(7):1420–1430PubMedCrossRefGoogle Scholar
  3. 3.
    Cristofanilli M (2006) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol 33(3 Suppl 9):S9–S14PubMedCrossRefGoogle Scholar
  4. 4.
    Alvero AB et al (2004) Improved method for the detection of cytokeratin 19-positive cells in the peripheral blood of breast cancer patients. Lab Invest. 84(5):658–661PubMedCrossRefGoogle Scholar
  5. 5.
    Allard WJ et al (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10(20):6897–6904PubMedCrossRefGoogle Scholar
  6. 6.
    Braun S, Marth C (2004) Circulating tumor cells in metastatic breast cancer—toward individualized treatment? N Engl J Med 351(8):824–826PubMedCrossRefGoogle Scholar
  7. 7.
    Braun S, Naume B (2005) Circulating and disseminated tumor cells. J Clin Oncol 23(8):1623–1626PubMedCrossRefGoogle Scholar
  8. 8.
    Budd GT et al (2006) Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer. Clin Cancer Res 12(21):6403–6409PubMedCrossRefGoogle Scholar
  9. 9.
    Hayes DF et al (2006) Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12(14 Pt 1):4218–4224PubMedCrossRefGoogle Scholar
  10. 10.
    Witzig TE et al (2002) Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res 8(5):1085–1091PubMedGoogle Scholar
  11. 11.
    Webster DR, Sabbadini E (1967) The prognostic significance of circulating tumor cells: a five-year follow-up study of patients with cancer of the breast. Can Med Assoc J 96(3):129–131PubMedGoogle Scholar
  12. 12.
    Sabbatini R et al (2000) Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J Clin Oncol 18(9):1914–1920PubMedGoogle Scholar
  13. 13.
    Ring AE et al (2005) Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer 92(5):906–912PubMedCrossRefGoogle Scholar
  14. 14.
    Ts’o PO et al (1997) Detection of intact prostate cancer cells in the blood of men with prostate cancer. Urology 49(6):881–885PubMedCrossRefGoogle Scholar
  15. 15.
    Wang ZP et al (2000) Identification and characterization of circulating prostate carcinoma cells. Cancer 88(12):2787–2795PubMedCrossRefGoogle Scholar
  16. 16.
    Muller V et al (2005) Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 11(10):3678–3685PubMedCrossRefGoogle Scholar
  17. 17.
    Muller V, Pantel K (2004) Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives. Breast Cancer Res 6(6):258–261PubMedCrossRefGoogle Scholar
  18. 18.
    Muller V, Pantel K (2005) BM micrometastases and circulating tumor cells in breast cancer patients: where have we been, where are we now and where does the future lie? Cytotherapy 7(6):478–482PubMedCrossRefGoogle Scholar
  19. 19.
    Tang C, Lin AY (2004) Circulating epithelial cells in breast cancer. N Engl J Med 351(23):2452–2454; author reply 2452–2454PubMedCrossRefGoogle Scholar
  20. 20.
    Taback B et al (2001) Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res 61(24):8845–8850PubMedGoogle Scholar
  21. 21.
    Gaforio JJ et al (2003) Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int J Cancer 107(6):984–990PubMedCrossRefGoogle Scholar
  22. 22.
    Fehm T et al (2002) Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 8(7):2073–2084PubMedGoogle Scholar
  23. 23.
    Fehm T et al (2005) Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. Cytotherapy 7(2):171–185PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2007

Authors and Affiliations

  • Katherine H. Rak Tkaczuk
    • 1
    Email author
  • Olga Goloubeva
    • 1
  • Nancy S. Tait
    • 1
  • Faye Feldman
    • 1
  • Ming Tan
    • 1
  • Zhao-Ping Lum
    • 2
  • Stephen A. Lesko
    • 2
  • David A. Van Echo
    • 2
  • Paul O. P. Ts’o
    • 2
  1. 1.University of Maryland Marlene and Stewart Greenebaum Cancer CenterBaltimoreUSA
  2. 2.CCC Diagnostics, LLCBaltimoreUSA

Personalised recommendations